Delivery Order SPE2DB20D2104-SPE2DB24FR88B
- Not listed
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $39,460.12 firm fixed-price delivery order is for the supply of STELARA 90 MG/ML SYRINGE syringes. The contract has an ultimate completion date of May 9, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical division, which serves as the primary vehicle...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $9,366.01 firm fixed-price delivery order is for the supply of STELARA 90 MG/ML syringes and has a completion date of June 21, 2023. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the company to deliver a comprehensive range of...
- This federal contract award is to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of STELARA 90 MG/ML SYRINGEML medical products. The $18,460.64 fixed-price delivery order was awarded by the Defense Logistics Agency (DLA), a defense agency that supports the military's healthcare needs. The contract has an ultimate completion date of December 3, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $12,439.33 firm fixed-price delivery order is for the supply of Stelara 90 mg/mL syringes, with an ultimate completion date of December 19, 2023. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $14,915.88 firm-fixed-price delivery order contract is for the supply of STELARA 90 MG/ML SYRINGEML, a specialty pharmaceutical product, to support military healthcare programs. The contract has an ultimate completion date of October 25, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The $12,813.54 firm fixed-price delivery order is for the supply of STELARA 90 MG/ML SYRINGEML, a specialty pharmaceutical product. The award has an ultimate completion date of July 5, 2024. Amerisourcebergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
- This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $35,820.83 firm-fixed-price delivery order is for the supply of STELARA 90 MG/ML SYRINGEML, a specialty pharmaceutical product, with a period of performance through January 14, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves...
- This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of STELARA 90 MG/ML SYRINGEML, a specialty medication, with a ceiling value of $10,747.59 and a completion date of March 1, 2024. AmerisourceBergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which has a significant Indefinite Delivery Contract (IDC) with...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $46,337.92 firm fixed-price delivery order is for the supply of STELARA 90 MG/ML syringe, a specialty medication. The contract has an ultimate completion date of October 18, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of STELARA 90 MG/ML SYRINGE. The firm-fixed-price delivery order has a ceiling value of $6,715.70 and an ultimate completion date of June 17, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) worth up to $999,999,999.00 with DLA Troop Support Medical, which serves as the primary vehicle for the company to deliver a...
- SPE2DB20D2104Indefinite Delivery Contract
- SPE2DB20D2104-SPE2DB24FR88BDelivery Order
This federal contract award was issued by the Defense Logistics Agency (DLA) to the prime contractor, Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $10,335.49 Firm Fixed Price delivery order is for the pharmaceutical product STELARA 90 MG/ML SYRINGEML. The contract has an ultimate completion date of January 3, 2024 and was awarded on January 2, 2024. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a broad range of pharmaceutical products and medical supplies to support military healthcare programs globally. This delivery order is not designated with a set-aside requirement, indicating it was awarded through full and open competition.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $10.3k | 1/2/24 |